NCT00666042View on ClinicalTrials.gov

Bioequivalence of Eye Drops and Spray Administration of Vigamox

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Cataract
Interventions
DRUG

Vigamox - administration in spray form

Vigamox will be administered in a spray form

DRUG

Vigamox eye drops

Vigamox eye drops

Trial Locations (1)

69089

Dept. of Ophthalmology, TAMC, Tel Aviv

Sponsors
All Listed Sponsors
lead

Advanced Ophthalmic Pharma

INDUSTRY

NCT00666042 - Bioequivalence of Eye Drops and Spray Administration of Vigamox | Biotech Hunter | Biotech Hunter